Patient recruitment was stopped prematurely after randomizing 888 patients (originally targeting 1623) at the request of an independent data and safety monitoring board as a result of a highly significant difference in the incidence rates of the composite primary end-point between both groups. 6 The study's design in detail, as well as early results, have previously been discussed in the Journal. 7 The investigators published 2-year follow-up results late last year in the New England Journal of Medicine ( Figure 1 ). 8 Results and discussion At two years, the rate of the primary end point was significantly lower in the PCI group compared to the OMT group (8.1% vs. 19.5%, hazard ratio with PCI = 0.39; 95% CI = 0.26 – 0.57; p < 0.001).
← all excerpts
FAME 2: Reshaping the approach to patients with stable coronary artery disease.
1
—
—